Any current/future new fundraising through debt or equity?

No immediate plans to repay debt; the company prefers to let debt reduce naturally through scheduled repayments (125 crores this year). Current gross debt stands at approximately 504 crores, with cash balances around 160 crores, resulting in net debt of about 340 crores. Management indicates the cost of borrowing has significantly reduced to sub-10% from around 17%. There is no explicit mention of new fundraising through debt or equity in the current period. Future decisions on debt repayment or new funding will depend on upcoming CAPEX requirements and growth projects, especially after comple

Any current/future capex/capital investment/strategic investment?

Current announced CAPEX is around ₹125 crores for doubling CPVC capacity and debottlenecking SIOP, with about ₹60 crores spent as of March 31 and 70% work done; some cost savings anticipated. Additional balance CAPEX of around ₹60 crores is required to complete announced projects. Routine CAPEX is about ₹30-40 crores. Total expected CAPEX spend including routine and announced projects for the year is around ₹100 crores. Future CAPEX includes making the Sahupuram facility chlorine neutral as part of ESG initiatives. Management is exploring renewable energy options like solar to reduce energy co

Future growth expectations in sales/revenue/volumes?

CPVC and SIOP segments expected to grow with strong demand; CPVC demand is growing in double digits, especially in lower-tier cities and rural India. SIOP capacity utilization increased to ~80% with consistent growth in revenues and margins; plans to expand footprint in European markets. Specialty chemicals to maintain margins north of 35% with increasing volumes starting Quarter 2 and Quarter 3. Commodity chemicals like caustic soda prices seen as bottomed out; expected recovery as China's domestic demand improves. Overall volumes expected to increase with capacity additions in CPVC and SIOP,

Future growth expectations in earnings/operating earnings/profits/EPS?

Annualized profit from CPVC and SIOP capacity expected to be north of ₹200 crores post capacity coming online; current year will see partial benefit (Page 16). Specialty chemicals (SIOP and CPVC) projected EBITDA: ₹115 crores this year and over ₹220 crores next year post capex (Page 14). EBITDA margin for CPVC and SIOP expected to remain north of 35% on increased volumes (Page 6). Total EBITDA expected to exceed ₹200 crores with contributions from PVC (5-7% margin), caustic (3-4% margin), and soda ash segments (Page 15). EPS expected to grow with increased volumes and profitability in specialt

DCW LtdQ4 FY23

DCW Ltd Q4 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹45.03P/E: 18.6Market Cap: ₹1.3K Cr

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

CPVC and SIOP segments expected to grow with strong demand; CPVC demand is growing in double digits, especially in lower-tier cities and rural India.
SIOP capacity utilization increased to ~80% with consistent growth in revenues and margins; plans to expand footprint in European markets.
Specialty chemicals to maintain margins north of 35% with increasing volumes starting Quarter 2 and Quarter 3.
Commodity chemicals like caustic soda prices seen as bottomed out; expected recovery as China's domestic demand improves.
Overall volumes expected to increase with capacity additions in CPVC and SIOP, providing annualized EBITDA north of ₹220 crores post capex.
Margins across segments expected to be maintained, with some quarter-to-quarter fluctuations due to price moves.
Company targets a balanced portfolio between specialty and commodity chemicals for sustainable margin protection.

Margin guidance

Category 3

Annualized profit from CPVC and SIOP capacity expected to be north of ₹200 crores post capacity coming online; current year will see partial benefit (Page 16).
Specialty chemicals (SIOP and CPVC) projected EBITDA: ₹115 crores this year and over ₹220 crores next year post capex (Page 14).
EBITDA margin for CPVC and SIOP expected to remain north of 35% on increased volumes (Page 6).
Total EBITDA expected to exceed ₹200 crores with contributions from PVC (5-7% margin), caustic (3-4% margin), and soda ash segments (Page 15).
EPS expected to grow with increased volumes and profitability in specialty chemicals and stabilization/recovery in commodity chemicals (implied across pages).
Interest cost reduction and strong free cash flow to support profitability; no immediate debt repayment planned, allowing internal accruals to fund growth (Page 14 & 9).
Long-term growth guided by capacity expansions, specialty chemical focus, and trading volumes (Pages 13, 11).

See what DCW Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

No immediate plans to repay debt; the company prefers to let debt reduce naturally through scheduled repayments (125 crores this year).
Current gross debt stands at approximately 504 crores, with cash balances around 160 crores, resulting in net debt of about 340 crores.
Management indicates the cost of borrowing has significantly reduced to sub-10% from around 17%.
There is no explicit mention of new fundraising through debt or equity in the current period.
Future decisions on debt repayment or new funding will depend on upcoming CAPEX requirements and growth projects, especially after completion of ongoing projects.
The company is considering internal accruals to fund future CAPEX.
No clear indication of equity fundraising or fresh debt issuance at present; the focus is on managing existing financial resources efficiently.

Order book

- The transcript does not explicitly mention the current or expected order book or pending orders. - However, there is an indication of growth and positive demand in segments like CPVC and SIOP, with capacity expansions underway and expected volume ramp-up starting Q3 FY24. - The company anticipates maintaining strong margins above 35% for specialty chemicals (SIOP and CPVC) with increased volumes. - Discussions show confidence in sustaining or improving EBITDA supported by additional volumes despite price corrections. - Management indicated stable operations with no mention of any backlog or pending orders causing concern. - The company is focused on completing announced projects quickly to support the next phase of growth, implying active order flow and production ramp-up aligned with capacity expansions. No direct order book numbers are provided in the transcript on page 17 or surrounding pages.

See what DCW Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Current announced CAPEX is around ₹125 crores for doubling CPVC capacity and debottlenecking SIOP, with about ₹60 crores spent as of March 31 and 70% work done; some cost savings anticipated.
Additional balance CAPEX of around ₹60 crores is required to complete announced projects.
Routine CAPEX is about ₹30-40 crores.
Total expected CAPEX spend including routine and announced projects for the year is around ₹100 crores.
Future CAPEX includes making the Sahupuram facility chlorine neutral as part of ESG initiatives.
Management is exploring renewable energy options like solar to reduce energy costs and carbon footprint.
After completing current projects, the company plans to evaluate the next growth driver for FY25, including possible geographic de-risking and further expansion.
Debt repayment decisions (₹125 crores repayment planned this year) will depend on CAPEX requirements and internal accruals.

Track DCW Ltd — get its next earnings analysis in your feed

How does DCW Ltd rank vs peers in ?

Pro feature

ThisDCW Ltd

Rev 3Mar 3

See where DCW Ltd sits in See which companies these are, and every other name in the sector.Open rankings

What DCW Ltd's management said in earlier quarters

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

DCW Ltd Q4 FY23 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

Continue your research

What DCW Ltd's management said in earlier quarters